BANK VONTOBEL/PUT/EDWARDS LIFESCIENCES/85/0.1/20.09.24 | Real-time Boerse Frankfurt Warrants 08:20:55 01/07/2024 pm IST | ||
| 0.201 EUR | +12.29% |
|
| 1 month | -51.62% | ||
| 3 months | -42.26% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about EDWARDS LIFESCIENCES CORPORATION
More news
| Date | Price | Change |
|---|---|---|
| 01/24/01 | 0.201 | +12.29% |
| 28/24/28 | 0.179 | +1.70% |
| 27/24/27 | 0.176 | -17.76% |
| 26/24/26 | 0.214 | -10.83% |
| 25/24/25 | 0.24 | +4.80% |
Real-time Boerse Frankfurt Warrants
Last update July 01, 2024 at 08:20 pm IST
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | PUT |
| Underlying | EDWARDS LIFESCIENCES CORPORATION |
| Issuer | 
Vontobel
|
| WKN | VD17TN |
| ISIN | DE000VD17TN2 |
| Date issued | 14/03/2024 |
| Strike | 85 $ |
| Maturity | 20/09/2024 (81 Days) |
| Parity | 10 : 1 |
| Emission price | 0.36 € |
| Emission volume | N/A |
| Settlement | Barausgleich |
| Currency | EUR |
Technical Indicators
| Highest since issue | 0.58 € |
|---|---|
| Lowest since issue | 0.176 € |
| Spread | 0.01 € |
| Spread % | 4.27% |
Company Profile
Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows:
- heart valves and surgery products (67.9%);
- hemodynamic monitoring systems (15.5%);
- other (16.6%): balloon catheters, artificial implants, etc.
Net sales are distributed geographically as follows: the United States (58.4%), Europe (22.2%), Japan (7.6%) and other (11.8%).
Sector
-
Ratings for Edwards Lifesciences Corporation
Trading Rating
Investor Rating
ESG Refinitiv
B+
Consensus: Edwards Lifesciences Corporation
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
31
Last Close Price
92.37
USD
Average target price
96.05
USD
Spread / Average Target
+3.99%
- Stock Market
- Warrants
- Warrant
